Skip to main content
. 2018 Sep 6;8:90. doi: 10.1186/s13550-018-0442-0

Fig. 3.

Fig. 3

Example of a patient with primary breast cancer exhibiting moderate tracer uptake of the primary tumor on 68Ga-Pentixafor PET (a) and corresponding moderate CXCR4 expression on immunohistochemistry (b)